Martingale Asset Management »

Denali Therapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $306k 19k 16.51

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Cisco Systems (CSCO)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Visa (V)
Exxon Mobil Corporation (XOM)
Wal-Mart Stores (WMT)
NVIDIA Corporation (NVDA)
MasterCard Incorporated (MA)

View all positions for Martingale Asset Management

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
FMR
State Street Corporation
Temasek Holdings
Norges Bank Investment Management
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Capital Research Global Investors
Alliancebernstein
Geode Capital Management
Holocene Advisors

View all funds holding Denali Therapeutics